METASTATIC NON-SMALL CELL LUNG CANCER
Clinical trials for METASTATIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial halted after testing Radiation-Immunotherapy combo for tough lung cancers
Disease control TerminatedThis early-stage trial aimed to test the safety of combining a type of targeted, high-dose radiation (lung SBRT) with an immunotherapy drug (pembrolizumab) for patients with advanced non-small cell lung cancer that had worsened after standard treatments. The study planned to find…
Matched conditions: METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Custom-Made immune cells target stubborn lung cancer
Disease control TerminatedThis early-stage study tested a personalized treatment for advanced lung cancer that had stopped responding to standard immunotherapy. Doctors collected a patient's own tumor-fighting immune cells, grew them in a lab, and reinfused them along with other immune-boosting drugs. The…
Matched conditions: METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: AbelZeta Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC